- Active, not recruiting
NCT02315716: Phase 2 -Carfilzomib/Cyclophosphamide/Dex With Maint. Carfilzomib - NDMM Cardamon Study
Updated: Aug 27, 2022
Cardamon Study
KCd

Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Multiple Myeloma (Cardamon)
The Cardamon trial is a phase 2 trial using the standard chemotherapy drugs cyclophosphamide and dexamethasone in combination with a new drug called Carfilzomib in patients with multiple myeloma.
Sponsor
University College, London
Collaborator
Amgen
UK Study
ClinicalTrials.gov Identifier: NCT02315716
Official Title: Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Untreated Transplant-eligible Patients With Symptomatic MM to Evaluate the Benefit of Upfront ASCT
First Posted : December 12, 2014
Click here for details on ClinicalTrials.gov
Carfilzomib : National Cancer Institute
Carfilzomib : MedlinePlus Drug Information